Symptom Improvements in Gastroesophageal Reflux Disease (GERD) Patients

NCT00394472 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

244

Enrollment

INDUSTRY

Sponsor class

Conditions

Gastroesophageal Reflux Disease (GERD)

Interventions

DRUG: AZD3355

Sponsor

AstraZeneca